Abstract
Patients with lymphoproliferative disorders such as chronic lymphocytic leukemia and mantle cell lymphoma (MCL) who are resistant to covalent Bruton t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
